BCG VACCINE SSI

This brand name is authorized in Estonia, Hong Kong, Ireland, Lithuania, Tunisia, South Africa

Active ingredients

The drug BCG VACCINE SSI contains one active pharmaceutical ingredient (API):

1 Bacillus Calmette-Guérin, Danish strain 1331, live attenuated UNII D3GOY6203T - MYCOBACTERIUM BOVIS BCG

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known. Read about BCG vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AN01	Tuberculosis, live attenuated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AN Tuberculosis vaccines
Discover more medicines within J07AN01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1849989, 1852949
Country: HK	Department of Health Drug Office	Identifier(s): 44952, 46273
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1013929, 1060926, 1089206
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3223011
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/30.1/0643